Literature DB >> 21819285

Aluminum toxicokinetics in peritoneal dialysis patients.

Corinne Seng Yue1, Megan Christie, Valery Lavergne, Tabo Sikaneta, Hulya Taskapan, Karine Mardini, Paul Tam, Robert Ting, Marc Ghannoum.   

Abstract

CONTEXT: Despite the risk of aluminum (Al) toxicity in dialysis patients, little is known about its toxicokinetics (TK) in this population. A national contamination of dialysate solutions with Al provided the opportunity to study Al TK in peritoneal dialysis (PD) patients and to better understand the influence of covariates on its disposition.
METHODS: Al levels in serum and dialysate as well as other laboratory values were collected prospectively from 83 PD patients after correction of Al contamination. Population TK analyses were conducted with NONMEM VI using standard model discrimination criteria. Covariate analyses were also performed using stepwise forward regression followed by backward deletion.
RESULTS: After correction of Al exposure, serum levels declined in a biphasic manner, which was captured by the TK model. The TK of Al were best described by a 2-compartment model with linear elimination. Total creatinine clearance was a significant covariate for total clearance (CL). Mean parameter estimates for volume of central compartment (V1), CL, volume of peripheral compartment (V2), volume of distribution at steady-state (Vss), and intercompartmental clearance (Q) were 168 L, 8.99 L/day, 12 000 L, 12 168 L, and 4.93 L/day, respectively. Inter-individual variability for CL and V2 were 22.6 and 51.1%, respectively. Al distributional half-life was 8.5 days, while the terminal elimination half-life was 7.2 years. This model confirms that the large Vss reflects the widespread distribution of Al in bone, lungs, liver, and other tissues.
CONCLUSION: This study describes the first population Al TK model in a large group of PD patients, which includes a covariate effect. The model confirms the extensive half-life and tissue distribution of Al in a dialysis-dependent population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21819285     DOI: 10.3109/15563650.2011.602083

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  6 in total

Review 1.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

Review 2.  Aluminum transfer during dialysis: a systematic review.

Authors:  Joëlle Mardini; Valery Lavergne; Marc Ghannoum
Journal:  Int Urol Nephrol       Date:  2014-06-18       Impact factor: 2.370

3.  Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis.

Authors:  Po-Hsun Chuang; Kai-Fan Tsai; I-Kuan Wang; Ya-Ching Huang; Lan-Mei Huang; Shou-Hsuan Liu; Cheng-Hao Weng; Wen-Hung Huang; Ching-Wei Hsu; Wen-Chin Lee; Tzung-Hai Yen
Journal:  Int J Environ Res Public Health       Date:  2022-03-24       Impact factor: 3.390

4.  Zinc supplementation alters plasma aluminum and selenium status of patients undergoing dialysis: a pilot study.

Authors:  Chih-Hung Guo; Pei-Chung Chen; Guoo-Shyng W Hsu; Chia-Liang Wang
Journal:  Nutrients       Date:  2013-04-22       Impact factor: 5.717

Review 5.  Layered double hydroxide nanocomposite for drug delivery systems; bio-distribution, toxicity and drug activity enhancement.

Authors:  Aminu Umar Kura; Mohd Zobir Hussein; Sharida Fakurazi; Palanisamy Arulselvan
Journal:  Chem Cent J       Date:  2014-08-10       Impact factor: 4.215

6.  Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging.

Authors:  Sixiang Shi; Brianne C Fliss; Zi Gu; Yian Zhu; Hao Hong; Hector F Valdovinos; Reinier Hernandez; Shreya Goel; Haiming Luo; Feng Chen; Todd E Barnhart; Robert J Nickles; Zhi Ping Xu; Weibo Cai
Journal:  Sci Rep       Date:  2015-11-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.